CIK 0001326732
- Accelerated filer
Xencor Inc
Sign in to watch- Ticker
- XNCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 201622502
- Phone
- +1 626-305-5900
- Business address
- 465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
- 4 Open-market sale SR. VICE PRESIDENT & CSO sold 2,663 shares at $11.90 ($31,677)
- 4 Grant or award SR. VICE PRESIDENT & CFO acquired 19,458 shares (grant or award)
- 4 Open-market sale SVP, GENERAL COUNSEL sold 1,492 shares at $11.90 ($17,747)
- 4 Open-market sale PRESIDENT & CEO sold 6,758 shares at $11.90 ($80,387)
- 4 Exercise or conversion SR. VICE PRESIDENT & CSO acquired 5,322 shares (option exercise)
- 4 Open-market sale SR. VICE PRESIDENT & CSO sold 73,367 shares at $15.72 ($1,153,329)
- 4 Open-market sale PRESIDENT & CEO sold 114,377 shares at $15.71 ($1,796,863)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 2,215 shares at $9.22 ($20,422)
- 4 Grant or award Director acquired 13,686 shares (grant or award)
- 4 Planned sale Director sold 2,993 shares at $9.22 ($27,595)
- 4 Planned sale Director sold 3,173 shares at $9.22 ($29,255)
- 4 Planned sale Director sold 2,993 shares at $9.22 ($27,595)
- 4 Grant or award Director acquired 13,686 shares (grant or award)
- 4 Planned sale Director sold 2,993 shares at $9.22 ($27,595)
- 4 Open-market sale EVP, Chief Development Officer sold 4,616 shares at $11.03 ($50,914)
- 4 Open-market sale SR. VICE PRESIDENT & CFO sold 3,750 shares at $8.06 ($30,233)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 2 of 21 · 415 filings